Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2021
Lipidomics analysis of monocytes from patients with acute myocardial infarction reveals lactosylceramide as a new player in monocyte migrationSusanna Fiorelli, Andrea Anesi, Benedetta Porro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2018
Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicitySonia Gioffré, Veronica Ricci, Chiara Vavassori, et al.
Autophagy|November 27, 2014
IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosisAna I Rovetta, Delfina Peña, Rodrigo E Hernández Del Pino, et al.
Antioxidants & Redox Signaling|September 24, 2017
Does Fluoroscopy Induce DNA Oxidative Damage in Patients Undergoing Catheter Ablation?Linda Turnu, Benedetta Porro, Valentina Alfieri, et al.
Frontiers in Cardiovascular Medicine|August 13, 2021
Aortic Valve Sclerosis in High-Risk Coronary Artery Disease PatientsVeronika A Myasoedova, Stefano Genovese, Laura Cavallotti, et al.
Biomolecules|August 26, 2022
Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy PatientsMelania Lippi, Mattia Chiesa, Ciro Ascione, et al.
Biomedicines|August 27, 2021
Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic ApproachAlessandro Di Minno, Roberta Clara Orsini, Mattia Chiesa, et al.
Cell Death & Disease|January 27, 2019
CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cellsEduardo Silva-Pavez, Paulina Villar, César Trigo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 7, 2023
Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistanceCelia N Pérez, Cristian R Falcón, Johinna Delgado Mons, et al.
ESMO Open|October 30, 2025
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)K-L Koster, I Colombo, S Hayoz, et al.
Pageof 21